According to Theravance Biopharma 's latest financial reports the company's current revenue (TTM ) is $80.32 Million USD. In 2024 the company made a revenue of $64.38 Million USD an increase over the revenue in the year 2023 that were of $57.42 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.